• Explore /
  • Poster
  • / A phase II study of oxaliplatin/5FU/bevacizumab and concurrent pelvic radiation in patients with simultaneous primary and metastatic rectal cancer: The Chrome-B trial.

A phase II study of oxaliplatin/5FU/bevacizumab and concurrent pelvic radiation in patients with simultaneous primary and metastatic rectal cancer: The Chrome-B trial.

Abstract Poster

Authors

null

Michael Michael

University of Melbourne, Melbourne, Australia

Michael Michael , Julie Chu , Mathias Bressel , Joseph McKendrick , Prasad Cooray , Sarat Chander , Michael Jefford , Marijana Vanevski , Rachel Wong , Malcolm Steel , Trevor Leong , Alexander Graham Heriot , Sam Ngan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

ACTRN12611000033943

Citation

J Clin Oncol 34, 2016 (suppl; abstr 3613)

DOI

10.1200/JCO.2016.34.15_suppl.3613

Abstract #

3613

Poster Bd #

310

Abstract Disclosures

Similar Posters

First Author: Steven J. Cohen

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.

Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.

First Author: Janice Zhao

First Author: Davide Melisi

First Author: Al Bowen Benson III